Premier Path Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Premier Path Wealth Partners's AMGN Position: Q2 2026 in Review
Premier Path Wealth Partners increased its Amgen (AMGN) stake by 2.4% in Q2 2026, buying an estimated $51K and bringing the position to 6,238 shares worth $2.26M. The position accounts for 0.26% of the portfolio, ranked #90.
Premier Path Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Premier Path Wealth Partners held 6,238 shares of Amgen worth $2.26M as of Q2 2026.
- Premier Path Wealth Partners bought 149 Amgen shares in Q2 2026, an estimated $51K.
- Amgen made up 0.26% of Premier Path Wealth Partners's portfolio in Q2 2026, its #90 holding.
- Premier Path Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.